CT-1812 CAS:1802632-22-9
CT-1812
Catalog # | Pkg Size | Price(USD) | Quantity | Buy this product |
---|---|---|---|---|
R-C-2100 | 50mg | 925.00 | + Add to cart |
|
R-C-2100 | 100mg | 1250.00 | + Add to cart |
|
R-C-2100 | 200mg | 1750.00 | + Add to cart |
|
|
Product description
CT-1812 is a first-in-class,orally available sigma-2/PGRMC1 antagonist(alpha beta oligomer receptor antagonist),is being developed by Cognition.sCT-1812 is a novel therapeutic candidate for Alzheimer is disease.
Appearance | N/A |
---|---|
Molecular Weight | N/A |
purity | >95% |
PDI by GPC | <1.5 |
Solubility | N/A |
Storage | -20℃, protected from light and moisture |
Transportation | 4-25℃ temperature for up to 3 weeks |
Stability | 2 years |
Document
Related Product